ClinicalTrials.gg
CompletedNCT03278964Updated Aug 13, 2019

Analysis Between the Results of Two Surgical Techniques of Orbital Decompression in Patients With Graves Orbitopathy

An interventional study of Orbital decompression in Graves Ophthalmopathy, sponsored by University of Sao Paulo General Hospital. Completed at 1 site in Brazil. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2019-08-13.

Sponsored by University of Sao Paulo General Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 6 months after the study started (first participant enrolled Feb 2015, registered Sep 2017).
Phase
Not applicable
Study type
Interventional
Enrollment
42
Allocation
Randomized
Ages
21 Years and older
Sex
All
01

Study summary

Randomized prospective clinical trial, aiming to compare two techniques of orbital decompression. Patients with Graves orbitopathy in the inactive phase for at least 6 months will be divided in two groups; one group will be submitted to orbital decompression by antro-ethmoidal technique; the other group will be submitted to orbital decompression by lateral wall technique. Patients will be followed up for a period of 6 months after the surgery, and will be evaluated about the effect of orbital decompression on ocular motility, proptosis, ocular surface and quality of life.

Read the detailed description

Graves' orbitopathy is the most relevant non-thyroid manifestation of Graves' disease. Its clinical status varies from subclinical to severe deformities. Clinical features include palpebral retraction, exophthalmos, restrictive strabismus, chemosis, ocular surface lesions and optic neuropathy. There are two stages of the disease. There is an active phase in which the inflammatory process is present and the orbital changes evolve. The inactive phase comprises a stable clinical picture regarding the sequelae of the active phase. Orbital decompression surgery is the main treatment procedure for this inactive phase for functional and cosmetic rehabilitation purposes. In the last decades, great advances in the techniques and indication of this surgery have been observed. However, a consensus about the ideal technique does not yet exist. The most commonly used techniques are antro-ethmoidal decompression and lateral wall decompression alone or associated with other walls. The present study will be based on patients with Graves' orbitopathy diagnosis for at least 2 years and who are already in the inactive phase for at least 6 months. There are no prospective studies comparing the 2 main orbital decompression techniques through a detailed analysis of surgical outcomes from computed tomography images, digital photographic images and ocular motility examination. These informations will be collected in the preoperative and postoperative periods. The investigators will evaluate the decompressive potential of each technique calculated by the tomographic images. Participants will be followed up for a period of 6 months after the surgical procedure and the effect of decompression on ocular motility, ocular bulb positioning, ocular surface, vertical palpebral fissure, and the patient's quality of life will also be analyzed. The findings of this work will bring important contribution to the improvement of this surgical procedure of great relevance in the rehabilitation of patients with Graves' orbitopathy.

02

Conditions studied

  • Graves Ophthalmopathy

Keywords

  • Graves Disease
  • Orbital decompression
  • Graves Orbitopathy
  • Exophthalmos
  • Diplopia
  • Restrictive Strabismus
03

In context

Graves Ophthalmopathy

199 studies on the registry are indexed under Graves Ophthalmopathy; 58 are open to participants now.

This study's enrollment of 42 is below the median of 63 across 146 interventional studies indexed under Graves Ophthalmopathy.

Browse Graves Ophthalmopathy studies →

Lead sponsor

University of Sao Paulo General Hospital is the lead sponsor of 611 studies on the registry; 98 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of Graves orbitopathy for at least 2 years
  • Clinical Activity Score (CAS) \< 4 for at least 6 months
  • Agreement with the Form, which will be signed during the selection visit
  • Ability to come to periodic evaluations for 6 months after the orbital decompression
  • Absence of ocular abnormalities such as degenerative myopia, microphthalmia or anophthalmic cavity
  • Absence of orbital abnormalities such as previous fractures or congenital defects
  • Good collaboration for the exams
  • Euthyroidism
  • Exophthalmus ≥ 20 mm in Hertel's exophthalmometry
  • Preoperative clinical evaluation indicating absence of for a surgical procedure

Exclusion criteria

Exclusion Criteria:

  • Myasthenia gravis
  • Pregnancy
  • Previous orbital, strabismus or eyelid surgery
  • Other abnormal eye conditions or symptoms that make it impossible to admit the patient to the study, according to the clinical judgment of the investigator.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
42 participants (actual)

Study arms

  • Active comparator
    Antro-ethmoidal technique

    Patients in the inactive phase of Graves orbitopathy will be submitted to orbital decompression by antro-ethmoidal technique.

    Procedure: Orbital decompression

  • Experimental
    Lateral wall technique

    Patients in the inactive phase of Graves orbitopathy will be submitted to orbital decompression by lateral wall technique.

    Procedure: Orbital decompression

Interventions

  • ProcedureOrbital decompression
06

What researchers measure

Primary outcomes

  1. Change in Ocular Motility status

    Measure by prism and cover, to assess strabismus in the nine positions of gaze

    Time frame: Before orbital decompression and 1, 3 and 6 months after surgery

  2. Exophthalmos

    Exophthalmos will be measured by Hertel's exophthalmometer and orbital computerized tomography

    Time frame: Before orbital decompression and 6 months after surgery

Secondary outcomes

  1. Diplopia

    Evaluation by Gorman's Diplopia Table

    Time frame: Before orbital decompression and 1, 3 and 6 months after surgery

  2. Digital photography evaluation

    Using digital photography, Photoshop and Image J, ductions and versions will be analyzed

    Time frame: Before orbital decompression and 6 months after surgery

  3. Volume of the extraocular muscles

    Measure by orbital computerized tomography images

    Time frame: Before orbital decompression and 6 months after surgery

  4. Ocular surface evaluation

    Assessed by Lysozyme Green, Break-up time, Schirmer I test

    Time frame: Before orbital decompression and 6 months after surgery

  5. Quality of life questionary Quality of life questionary

    GO-QoL form

    Time frame: Before orbital decompression and 6 months after surgery

07

Study locations

1 site
  • University of Sao Paulo General Hospital
    São Paulo, 05403000, Brazil
08

References and documents

Publications

  • Leite CA, Pereira TS, Chiang J, Moritz RB, Goncalves ACP, Monteiro MLR. Ocular motility changes after inferomedial wall and balanced medial plus lateral wall orbital decompression in Graves' orbitopathy: a randomized prospective comparative study. Clinics (Sao Paulo). 2021 Apr 9;76:e2592. doi: 10.6061/clinics/2021/e2592. eCollection 2021. PubMed 33852655 ↗
  • Leite CA, Pereira TS, Chiang J, Pieroni Goncalves AC, Monteiro MLR. Evaluation of Ocular Versions in Graves' Orbitopathy: Correlation between the Qualitative Clinical Method and the Quantitative Photographic Method. J Ophthalmol. 2020 Jul 31;2020:9758153. doi: 10.1155/2020/9758153. eCollection 2020. PubMed 32832143 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 13, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03278964
Responsible party
Cristiane de Almeida Leite (Medical Doctor, University of Sao Paulo General Hospital) — Principal investigator
First posted
Sep 12, 2017
Start date
Feb 5, 2015
Primary completion
Jan 31, 2019
Completion
Jan 31, 2019
Last update
Aug 13, 2019

Study contacts

MARIO L RIBEIRO MONTEIRO, PHD
study chair · University of Sao Paulo General Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion